HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96
9/28/2026
Impact: 75
Healthcare
HC Wainwright & Co. analyst Matthew Caufield has maintained a 'Buy' rating on Kodiak Sciences (NASDAQ: KOD) and increased the price target from $58 to $96.
AI summary, not financial advice
Share: